Nautilus Biotechnolgy
NAUT
NAUT
81 hedge funds and large institutions have $82.9M invested in Nautilus Biotechnolgy in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less capital invested
Capital invested by funds: $120M → $82.9M (-$36.7M)
Holders
81
Holding in Top 10
3
Calls
$3K
Puts
–
Top Buyers
| 1 | +$809K | |
| 2 | +$246K | |
| 3 | +$149K | |
| 4 |
Morgan Stanley
New York
|
+$136K |
| 5 |
State Street
Boston,
Massachusetts
|
+$89.8K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$877K | |
| 3 | -$790K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$658K |
| 5 |
SGM
Skye Global Management
West Palm Beach,
Florida
|
-$308K |